Ovarian cancer: Johnson & Johnson will have to pay 55 million dollars

This is the second unfavorable verdict for J&J, which last February paid 72 million dollars to another victim. The company will have to pay the sum as compensation after the allegations made regarding the correlation between their talcum powder and the onset of ovarian cancer.

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco